ASX - By Stock
|
NSB |
Re:
NSB - What does this company do?
|
|
Ahmed
|
28 |
4.0K |
2 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
28
|
4.0K
|
2
|
|
ASX - By Stock
|
AZS |
Re:
Ann: Change in Substantial Holding
|
|
Ahmed
|
11 |
3.2K |
2 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
11
|
3.2K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Potential 100 bagger Biotech missed by the market
|
|
Ahmed
|
467 |
93K |
3 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
467
|
93K
|
3
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Ahmed
|
51 |
6.7K |
1 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
51
|
6.7K
|
1
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Appendix 2A
|
|
Ahmed
|
51 |
6.7K |
6 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
51
|
6.7K
|
6
|
|
ASX - By Stock
|
NSB |
Re:
billion dollar company in the making
|
|
Ahmed
|
77 |
14K |
2 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
77
|
14K
|
2
|
|
ASX - By Stock
|
NSB |
Re:
billion dollar company in the making
|
|
Ahmed
|
77 |
14K |
1 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
77
|
14K
|
1
|
|
ASX - By Stock
|
APT |
Re:
Afterpay Valuation
|
|
Ahmed
|
5.0K |
1.7M |
2 |
11/07/20 |
11/07/20 |
ASX - By Stock
|
5.0K
|
1.7M
|
2
|
|
ASX - By Stock
|
APT |
Re:
UBS Sell and $17 target!
|
|
Ahmed
|
1.4K |
3.5M |
2 |
04/07/20 |
04/07/20 |
ASX - By Stock
|
1.4K
|
3.5M
|
2
|
|
ASX - By Stock
|
NSB |
Re:
Info 4 the sidelines
|
|
Ahmed
|
10 |
1.7K |
6 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
10
|
1.7K
|
6
|
|
ASX - By Stock
|
ELS |
Re:
Singapore Police Force
|
|
Ahmed
|
18 |
3.3K |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
18
|
3.3K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Exenatide Meets Key Endpoints in IIH Clinical Trial
|
|
Ahmed
|
18 |
6.1K |
3 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
18
|
6.1K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
One approach to calculate the value of Presendin
|
|
Ahmed
|
3 |
1.2K |
3 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
3
|
1.2K
|
3
|
|
ASX - By Stock
|
JIN |
Re:
heading to $13
|
|
Ahmed
|
314 |
191K |
0 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
314
|
191K
|
0
|
|
ASX - By Stock
|
NSB |
Re:
Ann: Trading Halt
|
|
Ahmed
|
24 |
3.9K |
5 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
24
|
3.9K
|
5
|
|
ASX - By Stock
|
NSB |
Re:
EmtinB discussion
|
|
Ahmed
|
25 |
11K |
0 |
29/08/19 |
29/08/19 |
ASX - By Stock
|
25
|
11K
|
0
|
|
ASX - By Stock
|
NSB |
Most Exciting Early Stage CNS Asset in Development
|
|
Ahmed
|
0 |
388 |
6 |
29/08/19 |
29/08/19 |
ASX - By Stock
|
0
|
388
|
6
|
|
ASX - By Stock
|
NSB |
Re:
Ann: NSB - Breakthrough results from Spinal Cord Injury Model
|
|
Ahmed
|
187 |
70K |
0 |
15/07/19 |
15/07/19 |
ASX - By Stock
|
187
|
70K
|
0
|
|
IPOs
|
|
Parazero Ltd- Drone Safety
|
|
Ahmed
|
4 |
2.4K |
0 |
06/05/18 |
06/05/18 |
IPOs
|
4
|
2.4K
|
0
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Appendix 4C - quarterly
|
|
Ahmed
|
17 |
7.8K |
1 |
30/04/18 |
30/04/18 |
ASX - By Stock
|
17
|
7.8K
|
1
|
|
ASX - By Stock
|
ELS |
Re:
ELS Chart
|
|
Ahmed
|
167 |
56K |
2 |
24/04/18 |
24/04/18 |
ASX - By Stock
|
167
|
56K
|
2
|
|
ASX - By Stock
|
ELS |
Re:
ELS Chart
|
|
Ahmed
|
167 |
56K |
0 |
31/03/18 |
31/03/18 |
ASX - By Stock
|
167
|
56K
|
0
|
|
ASX - By Stock
|
ELS |
Re:
ELS Chart
|
|
Ahmed
|
167 |
56K |
2 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
167
|
56K
|
2
|
|
ASX - By Stock
|
ELS |
Re:
ELS Chart
|
|
Ahmed
|
167 |
56K |
1 |
29/03/18 |
29/03/18 |
ASX - By Stock
|
167
|
56K
|
1
|
|
ASX - By Stock
|
ELS |
Re:
ELS Chart
|
|
Ahmed
|
167 |
56K |
1 |
16/03/18 |
16/03/18 |
ASX - By Stock
|
167
|
56K
|
1
|
|
ASX - By Stock
|
HMO |
Re:
Ann: HMO Continues Expansion in the US Entertainment Industry
|
|
Ahmed
|
1 |
1.6K |
3 |
06/03/18 |
06/03/18 |
ASX - By Stock
|
1
|
1.6K
|
3
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Institutional Placement Closes Well Oversubscribed
|
|
Ahmed
|
25 |
12K |
0 |
05/03/18 |
05/03/18 |
ASX - By Stock
|
25
|
12K
|
0
|
|
ASX - By Stock
|
HMO |
Re:
Ann: HearMeOut expands Ford relationship - launches in India
|
|
Ahmed
|
9 |
3.8K |
3 |
12/02/18 |
12/02/18 |
ASX - By Stock
|
9
|
3.8K
|
3
|
|
ASX - By Stock
|
HMO |
Re:
Ann: HearMeOut expands Ford relationship - launches in India
|
|
Ahmed
|
9 |
3.8K |
3 |
12/02/18 |
12/02/18 |
ASX - By Stock
|
9
|
3.8K
|
3
|
|
ASX - By Stock
|
HMO |
Re:
Its time
|
|
Ahmed
|
23 |
8.3K |
3 |
09/02/18 |
09/02/18 |
ASX - By Stock
|
23
|
8.3K
|
3
|
|
ASX - By Stock
|
HMO |
Re:
Its time
|
|
Ahmed
|
23 |
8.3K |
0 |
08/02/18 |
08/02/18 |
ASX - By Stock
|
23
|
8.3K
|
0
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
Ahmed
|
40 |
15K |
0 |
06/02/18 |
06/02/18 |
ASX - By Stock
|
40
|
15K
|
0
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
Ahmed
|
40 |
15K |
2 |
02/02/18 |
02/02/18 |
ASX - By Stock
|
40
|
15K
|
2
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Elsight Technology Critical to Protecting US Vice President
|
|
Ahmed
|
17 |
8.3K |
1 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
17
|
8.3K
|
1
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Elsight Technology Critical to Protecting US Vice President
|
|
Ahmed
|
17 |
8.3K |
1 |
22/01/18 |
22/01/18 |
ASX - By Stock
|
17
|
8.3K
|
1
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Clarification
|
|
Ahmed
|
29 |
10K |
2 |
16/01/18 |
16/01/18 |
ASX - By Stock
|
29
|
10K
|
2
|
|
ASX - By Stock
|
HMO |
Re:
New Audience
|
|
Ahmed
|
4 |
2.2K |
2 |
14/01/18 |
14/01/18 |
ASX - By Stock
|
4
|
2.2K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Welcome New Investors
|
|
Ahmed
|
290 |
61K |
6 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
290
|
61K
|
6
|
|
ASX - By Stock
|
ELS |
pre open
|
|
Ahmed
|
1 |
673 |
0 |
11/01/18 |
11/01/18 |
ASX - By Stock
|
1
|
673
|
0
|
|
ASX - By Stock
|
HMO |
Re:
Larry King LIVE NOW!
|
|
Ahmed
|
3 |
1.2K |
3 |
28/12/17 |
28/12/17 |
ASX - By Stock
|
3
|
1.2K
|
3
|
|
ASX - By Stock
|
HMO |
Larry King LIVE NOW!
|
|
Ahmed
|
3 |
1.2K |
5 |
20/12/17 |
20/12/17 |
ASX - By Stock
|
3
|
1.2K
|
5
|
|
ASX - By Stock
|
HMO |
Re:
HMO Communications
|
|
Ahmed
|
8 |
2.0K |
2 |
14/12/17 |
14/12/17 |
ASX - By Stock
|
8
|
2.0K
|
2
|
|
ASX - By Stock
|
HMO |
HMO Communications
|
|
Ahmed
|
8 |
2.0K |
3 |
13/12/17 |
13/12/17 |
ASX - By Stock
|
8
|
2.0K
|
3
|
|
ASX - By Stock
|
HMO |
Re:
Ann: HMO in Partnership with Legendary Broadcaster Larry King
|
|
Ahmed
|
18 |
2.9K |
2 |
04/12/17 |
04/12/17 |
ASX - By Stock
|
18
|
2.9K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Does Monash Universities research effect DXB?
|
|
Ahmed
|
3 |
808 |
7 |
03/12/17 |
03/12/17 |
ASX - By Stock
|
3
|
808
|
7
|
|
ASX - By Stock
|
HMO |
Re:
Ann: HearMeOut exceeds 500,000 downloads on Google Play store
|
|
Ahmed
|
6 |
1.8K |
3 |
01/12/17 |
01/12/17 |
ASX - By Stock
|
6
|
1.8K
|
3
|
|
ASX - By Stock
|
DXB |
DXB- Most Undervalued Biotech on ASX?
|
|
Ahmed
|
36 |
8.8K |
5 |
30/11/17 |
30/11/17 |
ASX - By Stock
|
36
|
8.8K
|
5
|
|
ASX - By Stock
|
HMO |
Re:
Ann: HearMeOut exceeds 500,000 downloads on Google Play store
|
|
Ahmed
|
6 |
1.8K |
5 |
29/11/17 |
29/11/17 |
ASX - By Stock
|
6
|
1.8K
|
5
|
|
ASX - By Stock
|
DXB |
FSGS Competitor Update
|
|
Ahmed
|
2 |
780 |
18 |
27/11/17 |
27/11/17 |
ASX - By Stock
|
2
|
780
|
18
|
|
ASX - By Stock
|
DXB |
Phase 2b Data Readout- ~12 months out !!
|
|
Ahmed
|
16 |
4.4K |
17 |
26/11/17 |
26/11/17 |
ASX - By Stock
|
16
|
4.4K
|
17
|
|